Predictors of Postoperative Urinary Incontinence After Holmium Laser Enucleation of the Prostate: 12 Months Follow-Up.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
02 2019
Historique:
received: 07 08 2018
revised: 21 11 2018
accepted: 23 11 2018
pubmed: 12 12 2018
medline: 15 5 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

To identify pre- and perioperative factors associated with incontinence after holmium laser enucleation of the prostate for benign prostatic hyperplasia. Retrospective review of our single-surgeon database identified 88 patients with 12 months' follow-up who underwent surgery between December 2014 and November 2016. Postoperative urinary incontinence was defined as 1 or more pads per day. Patients were evaluated at 6 weeks, 6 months, and 12 months postoperatively. Preoperative variables associated with incontinence at all follow-ups included pre-existing incontinence and higher detrusor voiding pressure. Higher maximum urinary flow and lower postvoid residual were predictors of transient urinary incontinence. On multivariate analysis, pre-existing incontinence remained significant as a 12-month predictor, whereas a higher detrusor voiding pressure was only significant as a 6-week predictor. De novo incontinence at 12 months was identified in only 1/44 patients (2%). Among patients with pre-existing incontinence, 30/40 (75%) reported resolution of their incontinence at 12 months. Numerous demographic, urinary, urodynamic, and operative factors were not significant for predicting incontinence. The mean decrease in pads per day between 6 weeks and 6 months was -1.6 and between 6 months and 12 months was -0.75. Medical management did not significantly impact rates of postoperative incontinence when compared to observation alone. Pre-existing urinary incontinence and/or higher detrusor voiding pressure may predict urinary incontinence 12 months after holmium laser enucleation of the prostate.

Identifiants

pubmed: 30528716
pii: S0090-4295(18)31264-0
doi: 10.1016/j.urology.2018.11.032
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

213-217

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Laura B Cornwell (LB)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY. Electronic address: cornwell@upstate.edu.

Garrett E Smith (GE)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY.

Jessica E Paonessa (JE)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH